A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners

作者: Lorraine Yap , Susan Carruthers , Sandra Thompson , Wendy Cheng , Jocelyn Jones

DOI: 10.1371/JOURNAL.PONE.0087564

关键词:

摘要: Background Hepatitis C virus infection (HCV) has a significant global health burden with an estimated 2%–3% of the world's population infected, and more than 350,000 dying annually from HCV-related conditions including liver failure cancer. Prisons potentially offer relatively stable environment in which to commence treatment as they usually provide good access care providers, are organised around routine structure. Uptake HCV, however, remains low community prisons. In this study, we explored factors affecting uptake inside prisons hypothesised that prisoners have unique issues influencing HCV consequence their incarceration not experienced other populations.

参考文章(36)
Heidi Coupland, Carolyn Day, Miriam T. Levy, Lisa Maher, Promoting equitable access to hepatitis C treatment for Indo-Chinese injecting drug users Health Promotion Journal of Australia. ,vol. 20, pp. 234- 240 ,(2009) , 10.1071/HE09234
David Lim, Tony Butler, D. Callander, National Prison Entrants’ Bloodborne Virus & Risk Behaviour Survey 2004, 2007, And 2010 Kirby Institute. pp. 1- 228 ,(2011)
Meaghan McLaren, Gary Garber, Curtis Cooper, Barriers to hepatitis C virus treatment in a Canadian HIV-hepatitis C virus coinfection tertiary care clinic. Canadian Journal of Gastroenterology & Hepatology. ,vol. 22, pp. 133- 137 ,(2008) , 10.1155/2008/949582
C. Treloar, J. Newland, J. Rance, M. Hopwood, Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals Journal of Viral Hepatitis. ,vol. 17, pp. 839- 844 ,(2010) , 10.1111/J.1365-2893.2009.01250.X
Karen Chan Osilla, Gery Ryan, Laveeza Bhatti, Matthew Goetz, Mallory Witt, Glenn Wagner, Factors that influence an HIV coinfected patient's decision to start hepatitis C treatment. Aids Patient Care and Stds. ,vol. 23, pp. 993- 999 ,(2009) , 10.1089/APC.2009.0153
Jason Grebely, Krista A. Genoway, Jesse D. Raffa, Gurbir Dhadwal, Tasleem Rajan, Grey Showler, Kate Kalousek, Fiona Duncan, Mark W. Tyndall, Chris Fraser, Brian Conway, Benedikt Fischer, Barriers associated with the treatment of hepatitis C virus infection among illicit drug users Drug and Alcohol Dependence. ,vol. 93, pp. 141- 147 ,(2008) , 10.1016/J.DRUGALCDEP.2007.09.008
Chia-Yen Dai, Treatment uptake of patients with chronic hepatitis C: can we expect and do more? Digestive Diseases and Sciences. ,vol. 55, pp. 3300- 3303 ,(2010) , 10.1007/S10620-010-1452-6
Josephine Norman, Nick M Walsh, Janette Mugavin, Mark A Stoové, Jenny Kelsall, Kirk Austin, Nick Lintzeris, The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users. Harm Reduction Journal. ,vol. 5, pp. 8- 8 ,(2008) , 10.1186/1477-7517-5-8